Editorial
All resources
Intro goes in here to talk about what this section is about and why it matters. This does not have to be very long but it would be good to give a bit of context. Context matters. So let us provide it here at this fantastic introductory sentence.
Links
Links that might be interesting to you.
ASCO living guideline on Treatment of multiple myeloma
ASCO’s living guideline covers treatment across the myeloma pathway. This update focuses on relapsed or refractory myeloma, recommending ciltacabtagene autoleucel and teclistamab plus daratumumab as preferred options at first relapse for eligible patients who have not previously received BCMA-directed treatment.
ASCO GuidelineBSH guideline on Early diagnosis of AL amyloidosis in haematology, cardiology, neurology, renal and general clinics
Read the British Society for Haematology guideline on early diagnosis of AL amyloidosis, including when to suspect it and when urgent haematology review may be needed.
BSH GuidelineBSH/UKMS guideline on Management of relapsed multiple myeloma
This British Society of Haematology and UK Myeloma Society guideline on the management of relapsed and refractory myeloma was developed to support clinicians making treatment decisions after disease progression following at least one prior line of treatment.
UKMRA Frailty Group guideline on Assessment and treatment of frail patients living with multiple myeloma
The UK Myeloma Research Alliance Frailty Group has published a new guideline on assessing and treating frailty in people with myeloma.
Other GuidelineIMS and IMWG consensus recommendations on the Definition of High-Risk Multiple Myeloma
The International Myeloma Society and International Myeloma Working Group have published updated consensus recommendations on the definition of high-risk myeloma.
BSH good practice paper on Diagnosis and management of monoclonal gammopathy of renal significance
The paper outlines a consensus approach to diagnosis, treatment and monitoring of MGRS, including guidance on the investigations required to confirm the condition, principles of supportive care, and haematological treatment strategies. It also highlights the need for ongoing multidisciplinary collaboration in managing this rare but clinically important disorder.
BSH GuidelineBSH/UKMS good practice paper on Advanced imaging for earlier diagnosis and morbidity prevention in myeloma
This Good Practice Paper from BSH/UKMS provides expert recommendations on the use of advanced imaging techniques, such as whole-body MRI and FDG-PET/CT, in the diagnosis and management of myeloma. It emphasises the importance of early detection of bone marrow disease to prevent complications and improve patient outcomes.
IMWG consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma
CAR T-cell therapy offers new treatment possibilities for advanced myeloma with high response rates. This expert-backed guidance supports clinicians in managing its unique effects safely and effectively.
IMWG GuidelineBSH/UKMS good practice paper on Diagnosis and initial treatment of transplant-eligible high-risk myeloma patients
The British Society for Haematology (BSH) and UK Myeloma Society (UKMS) have published a Good Practice Paper offering recommendations on the diagnosis and early treatment of transplant-eligible patients with high-risk myeloma.
IMWG immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma
Step into the forefront of myeloma treatment with this latest publication from the International Myeloma Working Group immunotherapy committee.
IMWG Guideline
Documents
Documents that might be interesting to you.
Developing a business case for a Myeloma Clinical Nurse Specialist
A practical guide to help healthcare professionals develop a business case for a Myeloma or Haematology Clinical Nurse Specialist, including evidence, financial planning, and sample job description and job plan tools.
Reducing language barriers: Patient Infosheet for your practice
Download a printable infosheet to help people living with myeloma find Myeloma UK support in multiple languages, including via telephone interpretation.
GP Diagnostic Tool for Wales
Wales-adapted myeloma diagnostic tool to support GPs with recognising symptoms, interpreting tests and making timely referrals.
GP Myeloma Diagnostic Tool in Welsh
Welsh-language myeloma diagnostic tool for primary care, with guidance on tests, interpretation and referral.
Amyloidosis diagnosis pathway
Developed by Myeloma Patients Europe (MPE), this visual pathway outlines key signs, symptoms and investigations to support early diagnosis of AL amyloidosis.
Raising awareness of myeloma in Black communities: posters for clinical use
As part of the Race Equality Foundation partnership project with Myeloma UK, a series of posters have been co-produced with people living with myeloma, carers and healthcare professionals.
Myeloma Nurse Guide – Bispecific antibodies
This myeloma nurse guide on bispecific antibodies supports nurses caring for people with relapsed or refractory myeloma. It explains treatment mechanisms, step-up dosing and pre-medications, and offers clear guidance on monitoring and managing side effects including CRS, ICANS, infection risk, and gastrointestinal or skin toxicities.
Consensus Framework for the Optimal Delivery of Bispecific Antibodies in Multiple Myeloma
Discover the EMMBRAce Project – a UK-wide initiative supporting hospitals in delivering bispecific antibody therapies to multiple myeloma patients. Explore resources, guidance, and educational tools designed to help healthcare providers deliver these life-changing treatments locally.
Myeloma Nurse Guide – Precursor conditions
This guide provides nurses with expert insights on managing precursor conditions to myeloma, including MGUS, MGRS, and smouldering myeloma. It covers essential monitoring, risk assessment, and patient care strategies to support early detection and improve patient outcomes.
Myeloma Nurse Guide – Infection
Infections stand as a primary cause of mortality among myeloma patients, emphasising the critical role of prevention, detection, and management in nursing care.
